UK markets closed

Cipher Pharmaceuticals Inc. (PHE.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
5.650.00 (0.00%)
At close: 09:16AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
22,143
21,162
20,675
21,943
21,607
Cost of revenue
4,147
4,069
3,992
3,684
3,057
Gross profit
18,308
17,093
16,683
18,259
18,550
Operating expenses
Research development
450
440
244
88
129
Selling general and administrative
5,631
5,393
4,400
5,112
6,257
Total operating expenses
7,254
7,060
5,633
5,200
6,386
Operating income or loss
10,742
10,033
11,050
13,059
12,164
Interest expense
-
-
-
92
323
Total other income/expenses net
129
778
-35
-1,920
-5,337
Income before tax
12,941
12,681
11,479
11,059
6,536
Income tax expense
-9,739
-7,702
-15,157
3,301
2,150
Income from continuing operations
22,680
20,383
26,636
7,758
4,386
Net income
22,680
20,383
26,636
7,758
4,549
Net income available to common shareholders
22,680
20,383
26,636
7,758
4,549
Basic EPS
1.28
0.82
1.05
0.29
0.17
Diluted EPS
1.26
0.80
1.03
0.29
0.17
Basic average shares
25,220
25,005
25,376
26,598
27,025
Diluted average shares
25,611
25,422
25,799
26,830
27,365